Abstract:OBJECTIVE: To study the expression of Cyclin B1(Ccnb1) in hepatocellular carcinoma (HCC) of different species including human, rat and tree shrew (tupaia), and to verify the feasibility of cross-species oncogenomics approach. METHODS: Real-time fluorescent quantitative polymerase chain reaction (Q-PCR) and Western Blot were applied to detect the expression levels of Cyclin B1 mRNA and protein levels in human(38 human HCC and Para-HCC tissues and 10 normal liver tissues), rat(15 HCC and Para-HCC tissues and 14 normal liver tissues), tree shrew(10 human HCC and para-HCC tissues and normal liver tissues), respectively. RESULTS: The expression of Cyclin B1 mRNA in HCC tissues of human(0.0114±0.0096) was significantly higher than that in normal liver tissues(0.0048±0.0029, P=0.033); while in HCC-adjacent tissues of human(0.0037±0.0027) was significantly lower than that in HCC tissues (P=0.002). There was no significant difference between HCC-adjacent tissues and normal liver tissues (P=0.609). The expression of Cyclin B1 mRNA in HCC tissues of rat(0.002 8±0.0019) was significantly higher than that in normal liver tissues(0.0006±0.0003, P=0.003); while in HCC-adjacent tissues of human(0.0029±0.0025) was significantly higher than that in normal liver tissues (P=0.001). There was no significant difference between HCC-adjacent tissues and HCC tissues (P=0.809). The expression of Cyclin B1 mRNA in HCC tissues of tree shew(0.014 8±0.0109) was significantly higher than that in normal liver tissues(0.0013±0.0009, P=0.007); while in HCC-adjacent tissues of human(0.0083±0.0064) it was significantly higher than that in normal liver tissues (P=0.060). There was no significant difference between HCC-adjacent tissues and HCC tissues (P=0.352). The expression of Cyclin B1 in the HCC tissue significantly correlated with the clinical stage, the Portal Vein Tumor Thrombus, the recurrence of tumor, the diameter of tumor and the differentiation of tumor, but did not correlated with the presence of extrahepatic metastasis, the number of tumor and the level of serum alpha-fetoprotein (AFP). The Western Blot analyses revealed a similar statistically significant trend. The expression of Cyclin B1 protein in HCC tissues of human(0.5707±0.2219) was significantly higher than that in HCC-adjacent tissues(0.4185±0.2543, P=0.005); while in HCC tissues it was significantly higher than that in normal liver tissues(0.3754±0.1270, P=0.019). The expression of Cyclin B1 protein in HCC tissues of rat(0.6619±0.3981) was significantly higher than that in normal liver tissues(0.3726±0.1048, P=0.039). The expression of Cyclin B1 protein in HCC tissues of tree shew(0.6563±0.2808) was significantly higher than that in HCC-adjacent tissues(0.4260±0.2015, P=0.046). CONCLUSIONS: The cross-species oncogenomics approach may represent a feasible and convenient process of identifying key molecules for human HCC. Cyclin B1 may be a particularly crucial molecule for hepatocarcinogenesis.

Biological Significance of the Expression of B-myb in Hepatocellular Carcinoma and the Correlation with Cyclin D1

Expression and Clinical Significance of B-myb in Hepatocellular Carcinoma

Expression and Clinical Significance of B-myb in Hepatocellular Carcinoma with the Application of Real Time Fluorescent Quantitative RT-PCR

Expression of Bcl-2,C-myc protein in hepatocellular carcinoma and its relation to prognosis

The expression of c-myb in HCC tissues and clinical significance

Expression of Cyclin A in Hepatocellular Carcinoma and Its Clinical Signific Ance

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Expression and Clinical Significance of Cyclin D1 VEGF and Flt-1 Protein in Primary Hepatocellular Carcinoma

[Expression of Cyclins in Hepatocellular Carcinoma and Its Correlation to Tumor Cell Apoptosis].

Expression and clinical significance of HBx and Beclin1 in hepatocellular carcinoma

Expression and significance of Cyclin B1 in hepatocellular carcinoma by cross-species research

The clinical significance of C-myc and P16 gene's expression in hepatocellular carcinoma

Expression of Bmi1 in Hepatocellular Carcinoma and Its Relationship with Cell Proliferation and Apoptosis

Role of β-catenin and cyclin D1 expressions in intrahepatic dissemination of liver cancer

Overexpression of Cyclin A in Hepatocellular Carcinoma and Its Relationship with HBx Gene Integration

Study on the expression and prognostic relationship of MYL6B in liver cancer based on bioinformatics

Expression of ERK-1 and Cyclin D1 in Hepatocellular Carcinoma

BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.

Increased Polycomb-Group Oncogene Bmi-1 Expression Correlates with Poor Prognosis in Hepatocellular Carcinoma

[Immunohistochemical Demonstration of Cyclins A, B, D1, D3 and E in Hepatocellular Carcinomas Using Tissue Microarrays].

Expression and Biological Significances of Bcl-2 Oncoprotein in Chronic Liver Diseases and Hepatocarcinomas